Nevertheless, innate immune cells are major type I IFN producers that influence cancer immunosurveillance [47, 48], therefore it is important to understand the cGAS-STING pathway mechanisms in these cells and whether it can be modulated indirectly by factors present in the TME. The gene discussed is STING1; the disease is cancer.